X @Bloomberg
Bloomberg·2025-08-18 07:14
Novo shares advanced after the drugmaker’s blockbuster weight-loss drug Wegovy received US approval to treat a serious form of liver disease https://t.co/Fi1V1nX2Rn ...
Novo shares advanced after the drugmaker’s blockbuster weight-loss drug Wegovy received US approval to treat a serious form of liver disease https://t.co/Fi1V1nX2Rn ...